Implantable Cardioverter Defibrillators Market By Product Type (Single Chamber, Dual Chamber); By Type (Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Cardiac Resynchronization Therapy Defibrillator (CRT-D)); By End Users (Hospitals and Clinics, Cardiac Care Centers, Ambulatory Surgical Centers, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
According to the World Health Organization (WHO) cardiovascular disease (CVD) is the main cause of death worldwide and one of the world's most serious health problems. CVD is a term that refers to a group of disorders that affect the heart or blood vessels. Cardio Stroke, heart failure, hypertension, rheumatic heart disease, peripheral arterial disease, and a variety of other vascular and cardiac issues are all included in this disorder. Major players in the healthcare industry are investing towards the development of advanced technologies and devices for cardiovascular and heart related diseases. Implantable cardioverter defibrillators have gained huge popularity as it is highly effective at terminating life-threatening ventricular arrhythmias and other cardiovascular diseases, thereby contributing towards the growth of implantable cardioverter defibrillators market.
Due to increased incidence of cardiovascular disease and improving healthcare infrastructure globally, emerging markets showcase enormous growth prospects for defibrillator manufacturers. Annual cardiovascular events in China are expected to rise by more than 50% during the period of 2010 to 2030, according to a report published by the American Heart Association. Manufacturers in the implantable cardioverter defibrillators market are keenly integrating advanced technologies such as real time monitoring into the devices, with an aim to enhance the efficiency of the device and serve a larger purpose for healthcare professionals and users at large. For instance in December 2021, a 67 year old female patient with a weak heart got the first Bluetooth enabled pacemaker, called cardiac resynchronization therapy defibrillator (CRT-D), implanted in India. The device will enable procurement of real-time updates about her heart condition on the mobile phone with a personalized application.
The covid-19 pandemic has had a severe effect on the cardiovascular system. Nearly a quarter of COVID-19 patients were diagnosed with cardiovascular problems, which account for nearly 40% of disease-related mortality. Patients admitted to hospitals with COVID-19 had more cardiac arrhythmias and even cardiac arrests. According to research done by scientists from Medtronic using their remote monitoring database (Carelink), it was studied that patients implanted with cardioverter defibrillators had experienced an increase in ICD shocks during the outbreak. However, promising technological advancements in defibrillators, is anticipated to fuel the growth of implantable cardioverter defibrillators market during the 2021-2029 period. Moreover, the increased promise of innovation in the cardiovascular diseases therapy arena promise new opportunities for growth of the market participants in the implantable cardioverter defibrillators market in the near future.
In terms of revenue, implantable cardioverter defibrillators market was valued at US$ 7048.44 Mn in 2020 growing at a CAGR of 3.9% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Implantable Cardioverter Defibrillators Market Revenue & Forecast, (US$ Million), 2015 – 2029
Product Type Outlook:
Based on product type, the segment is bifurcated into single chamber and dual chamber. Single chamber held the highest share in the global implantable cardioverter defibrillators market in 2020. Implantable cardioverter-defibrillators (ICDs) have a high rate of success in preventing ventricular tachycardia (VT) and ventricular fibrillation (VF), and they can protect patients from sudden cardiac death (SCD). Single chamber implantable cardioverter defibrillators poses some risks for misdiagnosis and hence dual chamber implantable cardioverter defibrillators are preferred more over the recent years for additional atrial information. However it is generally not recognised to use a dual-chamber device only for the purpose of detection, as the hazards associated with the second electrode may outweigh the benefits of detection. Linox SMART S DX, which is ventricular single chamber electrode with atrial sensing capabilities, designed by BIOTRONIK detects atrial impulses using two electrodes positioned at the atrial part of the ventricular electrode. Thus, such technological advancements in implantable cardioverter defibrillators are boosting the market growth globally.
Type Outlook:
Based on type, the global implantable cardioverter defibrillators market is segmented into subcutaneous implantable cardioverter defibrillators (S-ICDs), transvenous implantable cardioverter-defibrillator (T-ICDs), cardiac resynchronization therapy defibrillator (CRT-D). Transvenous implantable cardioverter-defibrillator (T-ICDs) held the highest share in the market in the year 2020. Transvenous implantable cardioverter defibrillator (ICD) is a small battery-powered electronic device which has been proven to lower the risk of death and sickness in those who experience life-threatening ventricular arrhythmias. These transvenous implantable cardioverter-defibrillator become the standard for those who have survived cardiac arrest and those who are at high risk of sudden cardiac arrest. There have been technological advances in transvenous implantable cardioverter defibrillator in the last few years, such as the development of leads, which was a significant step forward in the treatment of arrhythmias. Furthermore manufacturers have significantly improved product performance which have benefited many patients.
End User Outlook:
Based on end user segment, the global implantable cardioverter defibrillators market is segmented into hospitals and clinics, cardiac care centers, ambulatory surgical centers and others. Hospitals and clinics had the highest share in the market in the year 2020. In the recent decades, there have been huge advancements in medical and interventional treatments related to cardiovascular therapy. Patients with these diseases are frequently older and more complicated, with more severe disease and comorbidities, which also explains the steadily rising surgical risk. However, the technological advancements in heart surgery have helped in the preservation of disease and mortality rates despite of an increased risk. Furthermore government and healthcare organizations are investing in advanced technological devices for cardiovascular diseases, which is amongst the major factor for the growth in the global implantable cardioverter defibrillators market.
Region Outlook:
North America accounted for the highest share in the global implantable cardioverter defibrillators market in the year 2020. In the United States, heart disease is the leading cause of mortality for men, women, and people of most racial and ethnic groups. According to the U.S. Department of Health & Human Services, heart disease caused deaths of approximately 659,000 people in the country each year. Hence, in order to reduce the number of deaths caused due to cardiovascular diseases, major players in the market as well as government organizations are investing into advanced technologies for implantable cardioverter defibrillators and other devices to increase their efficiency. Moreover, United States and Canada are focused on strengthening the global healthcare infrastructure by increasing research and development capacity, improving early detection and treatment, mitigating disease risk factors, reshaping global health infrastructure to include cardiovascular disease treatment, forming global and public-private partnerships to address infrastructure and financial difficulties, and streamlining medical product development and supply.
Competitive Landscape
The report provides both, qualitative and quantitative research of implantable cardioverter defibrillators market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global implantable cardioverter defibrillators market are:
- Abbott
- BIOTRONIK SE & CO., KG
- Boston Scientific Corporation
- LivaNova PLC
- Medtronic plc
- MicroPort Scientific Corporation.
- Physio-Control, Inc.,
- Other Industry Participants
Global Implantable Cardioverter Defibrillators Market:
- By Product Type
- Single Chamber
- Dual Chamber
- By Type
- Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
- Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
- Cardiac Resynchronization Therapy Defibrillator (CRT-D)
- By End Users
- Hospitals and Clinics
- Cardiac Care Centers
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Implanted Cardioverter Defibrillator
Market
6. Market Synopsis:
Implanted Cardioverter Defibrillator Market
7. Implanted Cardioverter Defibrillator Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Implanted Cardioverter Defibrillator Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Implanted Cardioverter Defibrillator Market
7.6. Porter’s Five
Force Analysis
7.7. Impact of
Covid-19 on Implanted Cardioverter Defibrillator Market
8. Global Implanted Cardioverter Defibrillator Market Analysis
and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
8.2. Global
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
Product Type
8.2.1. Single
Chamber
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Dual
Chamber
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product Type
9. Global Implanted Cardioverter Defibrillator Market Analysis
and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
Type
9.2.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By Type
10. Global Implanted Cardioverter Defibrillator Market Analysis
and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
End-user
10.2.1. Hospitals
and Clinics
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Cardiac
Care Centers
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Ambulatory
Surgical Centers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
End-user
11. North America Implanted Cardioverter Defibrillator Market
Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
11.2. North
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Product Type
11.2.1. Single
Chamber
11.2.2. Dual
Chamber
11.3. North
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Type
11.3.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
11.3.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
11.3.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
11.4. North
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By End-user
11.4.1. Hospitals
and Clinics
11.4.2. Cardiac
Care Centers
11.4.3. Ambulatory
Surgical Centers
11.4.4. Others
11.5. North
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
11.5.1.1.1. Single Chamber
11.5.1.1.2. Dual Chamber
11.5.1.2. U.S Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
11.5.1.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
11.5.1.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
11.5.1.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.5.1.3. U.S Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
11.5.1.3.1. Hospitals and Clinics
11.5.1.3.2. Cardiac Care Centers
11.5.1.3.3. Ambulatory Surgical Centers
11.5.1.3.4. Others
11.5.2. Canada
11.5.2.1. Canada Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
11.5.2.1.1. Single Chamber
11.5.2.1.2. Dual Chamber
11.5.2.2. Canada Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
11.5.2.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
11.5.2.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
11.5.2.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.5.2.3. Canada Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
11.5.2.3.1. Hospitals and Clinics
11.5.2.3.2. Cardiac Care Centers
11.5.2.3.3. Ambulatory Surgical Centers
11.5.2.3.4. Others
11.5.3. Mexico
11.5.3.1. Mexico Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
11.5.3.1.1. Single Chamber
11.5.3.1.2. Dual Chamber
11.5.3.2. Mexico Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
11.5.3.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
11.5.3.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
11.5.3.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.5.3.3. Mexico Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
11.5.3.3.1. Hospitals and Clinics
11.5.3.3.2. Cardiac Care Centers
11.5.3.3.3. Ambulatory Surgical Centers
11.5.3.3.4. Others
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.4.1.1. Single Chamber
11.5.4.1.2. Dual Chamber
11.5.4.2. Rest of North America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Type
11.5.4.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
11.5.4.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
11.5.4.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
11.5.4.3. Rest of North America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By End-user
11.5.4.3.1. Hospitals and Clinics
11.5.4.3.2. Cardiac Care Centers
11.5.4.3.3. Ambulatory Surgical Centers
11.5.4.3.4. Others
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Product Type
11.6.3. By Type
11.6.4. By
End-user
12. Europe Implanted Cardioverter Defibrillator Market Analysis
and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
12.2. Europe
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
Product Type
12.2.1. Single
Chamber
12.2.2. Dual
Chamber
12.3. Europe
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
Type
12.3.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
12.3.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
12.3.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
12.4. Europe
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
End-user
12.4.1. Hospitals
and Clinics
12.4.2. Cardiac
Care Centers
12.4.3. Ambulatory
Surgical Centers
12.4.4. Others
12.5. Europe
Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.1. France
12.5.1.1. France Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
12.5.1.1.1. Single Chamber
12.5.1.1.2. Dual Chamber
12.5.1.2. France Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.1.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.1.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.1.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.1.3. France Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
12.5.1.3.1. Hospitals and Clinics
12.5.1.3.2. Cardiac Care Centers
12.5.1.3.3. Ambulatory Surgical Centers
12.5.1.3.4. Others
12.5.2. The UK
12.5.2.1. The UK Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
12.5.2.1.1. Single Chamber
12.5.2.1.2. Dual Chamber
12.5.2.2. The UK Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.2.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.2.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.2.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.2.3. The UK Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
12.5.2.3.1. Hospitals and Clinics
12.5.2.3.2. Cardiac Care Centers
12.5.2.3.3. Ambulatory Surgical Centers
12.5.2.3.4. Others
12.5.3. Spain
12.5.3.1. Spain Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
12.5.3.1.1. Single Chamber
12.5.3.1.2. Dual Chamber
12.5.3.2. Spain Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
12.5.3.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.3.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.3.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.3.3. Spain Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
12.5.3.3.1. Hospitals and Clinics
12.5.3.3.2. Cardiac Care Centers
12.5.3.3.3. Ambulatory Surgical Centers
12.5.3.3.4. Others
12.5.4. Germany
12.5.4.1. Germany Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
12.5.4.1.1. Single Chamber
12.5.4.1.2. Dual Chamber
12.5.4.2. Germany Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.4.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.4.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.4.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.4.3. Germany Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
12.5.4.3.1. Hospitals and Clinics
12.5.4.3.2. Cardiac Care Centers
12.5.4.3.3. Ambulatory Surgical Centers
12.5.4.3.4. Others
12.5.5. Italy
12.5.5.1. Italy Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
12.5.5.1.1. Single Chamber
12.5.5.1.2. Dual Chamber
12.5.5.2. Italy Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
12.5.5.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.5.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.5.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.5.3. Italy Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
12.5.5.3.1. Hospitals and Clinics
12.5.5.3.2. Cardiac Care Centers
12.5.5.3.3. Ambulatory Surgical Centers
12.5.5.3.4. Others
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.5.6.1.1. Single Chamber
12.5.6.1.2. Dual Chamber
12.5.6.2. Nordic Countries Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
12.5.6.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.6.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.6.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.6.3. Nordic Countries Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
12.5.6.3.1. Hospitals and Clinics
12.5.6.3.2. Cardiac Care Centers
12.5.6.3.3. Ambulatory Surgical Centers
12.5.6.3.4. Others
12.5.6.4. Nordic Countries Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.5.7.1.1. Single Chamber
12.5.7.1.2. Dual Chamber
12.5.7.2. Benelux Union Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
12.5.7.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.7.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.7.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.7.3. Benelux Union Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
12.5.7.3.1. Hospitals and Clinics
12.5.7.3.2. Cardiac Care Centers
12.5.7.3.3. Ambulatory Surgical Centers
12.5.7.3.4. Others
12.5.7.4. Benelux Union Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
12.5.8.1.1. Single Chamber
12.5.8.1.2. Dual Chamber
12.5.8.2. Rest of Europe Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
12.5.8.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
12.5.8.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
12.5.8.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
12.5.8.3. Rest of Europe Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
12.5.8.3.1. Hospitals and Clinics
12.5.8.3.2. Cardiac Care Centers
12.5.8.3.3. Ambulatory Surgical Centers
12.5.8.3.4. Others
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Product Type
12.6.3. By Type
12.6.4. By
End-user
13. Asia Pacific Implanted Cardioverter Defibrillator Market
Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia
Pacific Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
13.2. Asia
Pacific Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.2.1. Single
Chamber
13.2.2. Dual
Chamber
13.3. Asia
Pacific Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Type
13.3.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
13.3.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
13.3.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
13.4. Asia
Pacific Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By End-user
13.4.1. Hospitals
and Clinics
13.4.2. Cardiac
Care Centers
13.4.3. Ambulatory
Surgical Centers
13.4.4. Others
13.5. Asia
Pacific Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.1. China
13.5.1.1. China Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
13.5.1.1.1. Single Chamber
13.5.1.1.2. Dual Chamber
13.5.1.2. China Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
13.5.1.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.1.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.1.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.1.3. China Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
13.5.1.3.1. Hospitals and Clinics
13.5.1.3.2. Cardiac Care Centers
13.5.1.3.3. Ambulatory Surgical Centers
13.5.1.3.4. Others
13.5.2. Japan
13.5.2.1. Japan Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
13.5.2.1.1. Single Chamber
13.5.2.1.2. Dual Chamber
13.5.2.2. Japan Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
13.5.2.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.2.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.2.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.2.3. Japan Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
13.5.2.3.1. Hospitals and Clinics
13.5.2.3.2. Cardiac Care Centers
13.5.2.3.3. Ambulatory Surgical Centers
13.5.2.3.4. Others
13.5.3. India
13.5.3.1. India Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
13.5.3.1.1. Single Chamber
13.5.3.1.2. Dual Chamber
13.5.3.2. India Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
13.5.3.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.3.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.3.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.3.3. India Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
13.5.3.3.1. Hospitals and Clinics
13.5.3.3.2. Cardiac Care Centers
13.5.3.3.3. Ambulatory Surgical Centers
13.5.3.3.4. Others
13.5.4. New
Zealand
13.5.4.1. New Zealand Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
13.5.4.1.1. Single Chamber
13.5.4.1.2. Dual Chamber
13.5.4.2. New Zealand Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
13.5.4.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.4.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.4.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.4.3. New Zealand Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
13.5.4.3.1. Hospitals and Clinics
13.5.4.3.2. Cardiac Care Centers
13.5.4.3.3. Ambulatory Surgical Centers
13.5.4.3.4. Others
13.5.5. Australia
13.5.5.1. Australia Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
13.5.5.1.1. Single Chamber
13.5.5.1.2. Dual Chamber
13.5.5.2. Australia Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
13.5.5.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.5.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.5.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.5.3. Australia Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
13.5.5.3.1. Hospitals and Clinics
13.5.5.3.2. Cardiac Care Centers
13.5.5.3.3. Ambulatory Surgical Centers
13.5.5.3.4. Others
13.5.6. South
Korea
13.5.6.1. South Korea Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
13.5.6.1.1. Single Chamber
13.5.6.1.2. Dual Chamber
13.5.6.2. South Korea Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
13.5.6.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.6.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.6.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.6.3. South Korea Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
13.5.6.3.1. Hospitals and Clinics
13.5.6.3.2. Cardiac Care Centers
13.5.6.3.3. Ambulatory Surgical Centers
13.5.6.3.4. Others
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
13.5.7.1.1. Single Chamber
13.5.7.1.2. Dual Chamber
13.5.7.2. Southeast Asia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
13.5.7.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.7.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.7.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.7.3. Southeast Asia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
13.5.7.3.1. Hospitals and Clinics
13.5.7.3.2. Cardiac Care Centers
13.5.7.3.3. Ambulatory Surgical Centers
13.5.7.3.4. Others
13.5.7.4. Southeast Asia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.8.1.1. Single Chamber
13.5.8.1.2. Dual Chamber
13.5.8.2. Rest of Asia Pacific Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
13.5.8.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
13.5.8.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
13.5.8.3. Rest of Asia Pacific Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By End-user
13.5.8.3.1. Hospitals and Clinics
13.5.8.3.2. Cardiac Care Centers
13.5.8.3.3. Ambulatory Surgical Centers
13.5.8.3.4. Others
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Product Type
13.6.3. By Type
13.6.4. By
End-user
14. Middle East and Africa Implanted Cardioverter Defibrillator
Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle
East and Africa Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
14.2. Middle
East and Africa Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.2.1. Single
Chamber
14.2.2. Dual
Chamber
14.3. Middle East
and Africa Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Type
14.3.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
14.3.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
14.3.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
14.4. Middle
East and Africa Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
and Forecasts, By End-user
14.4.1. Hospitals
and Clinics
14.4.2. Cardiac
Care Centers
14.4.3. Ambulatory
Surgical Centers
14.4.4. Others
14.5. Middle
East and Africa Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
and Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.5.1.1.1. Single Chamber
14.5.1.1.2. Dual Chamber
14.5.1.2. Saudi Arabia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
14.5.1.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.1.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.1.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.1.3. Saudi Arabia Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
14.5.1.3.1. Hospitals and Clinics
14.5.1.3.2. Cardiac Care Centers
14.5.1.3.3. Ambulatory Surgical Centers
14.5.1.3.4. Others
14.5.2. UAE
14.5.2.1. UAE Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
14.5.2.1.1. Single Chamber
14.5.2.1.2. Dual Chamber
14.5.2.2. UAE Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
14.5.2.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.2.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.2.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.2.3. UAE Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
14.5.2.3.1. Hospitals and Clinics
14.5.2.3.2. Cardiac Care Centers
14.5.2.3.3. Ambulatory Surgical Centers
14.5.2.3.4. Others
14.5.3. Egypt
14.5.3.1. Egypt Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Product Type
14.5.3.1.1. Single Chamber
14.5.3.1.2. Dual Chamber
14.5.3.2. Egypt Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By Type
14.5.3.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.3.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.3.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.3.3. Egypt Implanted Cardioverter Defibrillator Market Revenue (US$
Mn) and Forecasts, By End-user
14.5.3.3.1. Hospitals and Clinics
14.5.3.3.2. Cardiac Care Centers
14.5.3.3.3. Ambulatory Surgical Centers
14.5.3.3.4. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
14.5.4.1.1. Single Chamber
14.5.4.1.2. Dual Chamber
14.5.4.2. Kuwait Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
14.5.4.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.4.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.4.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.4.3. Kuwait Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
14.5.4.3.1. Hospitals and Clinics
14.5.4.3.2. Cardiac Care Centers
14.5.4.3.3. Ambulatory Surgical Centers
14.5.4.3.4. Others
14.5.5. South
Africa
14.5.5.1. South Africa Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.5.5.1.1. Single Chamber
14.5.5.1.2. Dual Chamber
14.5.5.2. South Africa Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By Type
14.5.5.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.5.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.5.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.5.3. South Africa Implanted Cardioverter Defibrillator Market
Revenue (US$ Mn) and Forecasts, By End-user
14.5.5.3.1. Hospitals and Clinics
14.5.5.3.2. Cardiac Care Centers
14.5.5.3.3. Ambulatory Surgical Centers
14.5.5.3.4. Others
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Implanted Cardioverter
Defibrillator Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.6.1.1. Single Chamber
14.5.6.1.2. Dual Chamber
14.5.6.2. Rest of Middle East & Africa Implanted Cardioverter
Defibrillator Market Revenue (US$ Mn) and Forecasts, By Type
14.5.6.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
14.5.6.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
14.5.6.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
14.5.6.3. Rest of Middle East & Africa Implanted Cardioverter
Defibrillator Market Revenue (US$ Mn) and Forecasts, By End-user
14.5.6.3.1. Hospitals and Clinics
14.5.6.3.2. Cardiac Care Centers
14.5.6.3.3. Ambulatory Surgical Centers
14.5.6.3.4. Others
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Product Type
14.6.3. By Type
14.6.4. By
End-user
15. Latin America Implanted Cardioverter Defibrillator Market
Analysis and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn)
15.2. Latin
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.2.1. Single
Chamber
15.2.2. Dual
Chamber
15.3. Latin
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Type
15.3.1. Subcutaneous
Implantable Cardioverter Defibrillators (S-ICDs)
15.3.2. Transvenous
Implantable Cardioverter-Defibrillators (T-ICDs)
15.3.3. Cardiac
Resynchronization Therapy Defibrillator (CRT-D)
15.4. Latin
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By End-user
15.4.1. Hospitals
and Clinics
15.4.2. Cardiac
Care Centers
15.4.3. Ambulatory
Surgical Centers
15.4.4. Others
15.5. Latin
America Implanted Cardioverter Defibrillator Market Revenue (US$ Mn) and
Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
15.5.1.1.1. Single Chamber
15.5.1.1.2. Dual Chamber
15.5.1.2. Brazil Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
15.5.1.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
15.5.1.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
15.5.1.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
15.5.1.3. Brazil Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
15.5.1.3.1. Hospitals and Clinics
15.5.1.3.2. Cardiac Care Centers
15.5.1.3.3. Ambulatory Surgical Centers
15.5.1.3.4. Others
15.5.2. Argentina
15.5.2.1. Argentina Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Product Type
15.5.2.1.1. Single Chamber
15.5.2.1.2. Dual Chamber
15.5.2.2. Argentina Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By Type
15.5.2.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
15.5.2.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
15.5.2.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
15.5.2.3. Argentina Implanted Cardioverter Defibrillator Market Revenue
(US$ Mn) and Forecasts, By End-user
15.5.2.3.1. Hospitals and Clinics
15.5.2.3.2. Cardiac Care Centers
15.5.2.3.3. Ambulatory Surgical Centers
15.5.2.3.4. Others
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.3.1.1. Single Chamber
15.5.3.1.2. Dual Chamber
15.5.3.2. Rest of Latin America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By Type
15.5.3.2.1. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
15.5.3.2.2. Transvenous Implantable Cardioverter-Defibrillators (T-ICDs)
15.5.3.2.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
15.5.3.3. Rest of Latin America Implanted Cardioverter Defibrillator
Market Revenue (US$ Mn) and Forecasts, By End-user
15.5.3.3.1. Hospitals and Clinics
15.5.3.3.2. Cardiac Care Centers
15.5.3.3.3. Ambulatory Surgical Centers
15.5.3.3.4. Others
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Product Type
15.6.3. By Type
15.6.4. By
End-user
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2020
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. Abbott
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. BIOTRONIK SE & CO.KG
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business Strategies
17.3. Boston Scientific Corporation
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business Strategies
17.4. LivaNova PLC
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business Strategies
17.5. Medtronic plc
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business Strategies
17.6. MicroPort Scientific Corporation.
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business Strategies
17.7. Physio-Control, Inc.
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business Strategies
17.8. Other
Market Participants
18. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.